New eczema ointment shows promise in small trial
NCT ID NCT06923228
First seen Apr 10, 2026 · Last updated May 17, 2026 · Updated 6 times
Summary
This study tested a new ointment called CGB-500 for people aged 12 and older with atopic dermatitis (eczema). Participants applied the ointment and a comparison drug to different skin areas twice daily for four weeks. The goal was to see if CGB-500 safely reduces eczema severity. Only 3 people took part, so results are very early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Dermatology Clinical Research
Fremont, California, 94538, United States
Conditions
Explore the condition pages connected to this study.